Maslinic acid modulates glycogen metabolism by enhancing the insulin signaling pathway and inhibiting glycogen phosphorylase

Chinese Journal of Natural Medicines

Volumn 12, Issue 4, 2014, Pages 259-265

  Liu, Jun ^a   Wang, Xue ^a   Chen, Yu Peng ^a   Mao, Li Fei ^a   Shang, Jing ^a   Sun, Hong Bin ^b   Zhang, Lu Yong ^a  

^a China Pharmaceutical University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Glycogen metabolism; Glycogen phosphorylation a; Insulin signal transduction; Maslinic acid

Indexed keywords

GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; MASLINIC ACID; PROTEIN KINASE B; WORTMANNIN; ENZYME INHIBITOR; HERBACEOUS AGENT; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; HEPG2 CELL LINE; HYPERGLYCEMIA; HYPERINSULINEMIA; IC 50; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DIABETES MELLITUS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM;

ANIMALS; DIABETES MELLITUS; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; HEP G2 CELLS; HUMANS; INSULIN; MALE; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; TRITERPENES;

EID: 84901378828     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(14)60052-2     Document Type: Article

References (32)

1. Oikonomakos NG Glycogen phosphorylase as a molecular target for type 2 diabetes therapy [J]. Curr Protein Pep Sci 2002, 3(6):561-586.
2. Peetz D, Post F, Schinzel H, et al. Glycogen phosphorylase BB in acute coronary syndromes [J]. Clin Chem Lab Med 2005, 43(12):1351-1358.
3. Waagepetersen HS The effects of isofagomine, a potent glycogen phosphorylase inhibitor, on glycogen metabolism in cultured mouse cortical astrocytes [J]. Neurochem Inter 2000, 36(4-5):435-440.
4. Seyfried TN, Shelton LM Cancer as a metabolic disease [J]. Nutr Metab 2010, 7:7-28.
5. Bollen M, Keppens S, Stalmans W Specific features of glycogen metabolism in the liver [J]. Biochem J 1998, 336(Pt 1):19-31.
6. Dzubak P, Hajduch M, Vydra D, et al. Pharmacological activities of natural triterpenoids and their therapeutic implications [J]. Nat Prod Rep 2006, 23(3):394-411.
7. Taniguchi S, Imayoshi Y, Kobayashi E, et al. Production of bioactive triterpenes by Eriobotrya japonica calli [J]. Phytochemistry 2002, 59(3):315-323.
8. Xu HX, Zeng FQ, Wan M, et al. Anti-HIV triterpene acids from Geum japonicum [J]. J Nat Prod 1996, 59(7):643-645.
9. Montilla MP, Agil A, Navarro MC, et al. Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity [J]. Planta Med 2003, 69(5):472-474.
10. Wen XA, Sun HB, Liu J, et al. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: Synthesis, dtructure-activity relationships and X-ray crystallographic studies [J]. J Med Chem 2008, 51(12):3540-3554.
11. Chen J, Liu J, Zhang LY, et al. Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase [J]. Bioorg Med Chem Lett 2006, 16(11):2915-2919.
12. Cheng KG, Liu J, Liu XF, et al. Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase [J]. Carbohy Res 2009, 344(7):841-850.
13. Cheng KG, Zhang P, Liu J, et al. Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase [J]. J Nat Prod 2008, 71(11):1877-1880.
14. Hao J, Zhang P, Wen XA, et al. Efficient access to 2-isobetulinic acid, 2-isooleanolic acid and 2-isoursolic acid [J]. J Org Chem 2008, 73(18):7405-7408.
15. Wen XA, Xia J, Cheng KG, et al. Pentacyclic triterpenes. Part 5: Synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases [J]. Bioorg Med Chem Lett 2007, 17(21):5777-5782.
16. Wen XA, Zhang P, Liu J, et al. Pentacyclic triterpenes. Part 2: Synthesis and biological activity of maslinic acid derivatives as inhibitors of glycogen phosphorylase [J]. Bioorg Med Chem Lett 2006, 16(3):722-726.
17. Zhang LY, Chen J, Gong YC, et al. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylase [J]. Chem Biodiv 2009, 6(6):864-874.
18. Zhang P, Hao J, Liu J, et al. Efficient synthesis of morolic acid and related triterpenes starting from betulin [J]. Tetrahedron 2009, 65(22):4304-4309.
19. Liu J, Sun HB, Duan WG, et al. Maslinic acid reduces blood glucose and body weight in KK-Ay mice [J]. Biol Pharm Bull 2007, 30(11):2075-2078.
20. Liu J, Sun HB, Wang XF, et al. Effects of oleanolic acid and maslinic acid on hyperlipidemia [J]. Drug Develop Res 2007, 68(5):261-266.
21. Liu J, He T, Lu Q, et al. Asiatic acid preserves beta mass and mitigates hyperglycemia in streptozocin-induced diabetic rats [J]. Diabetes Metab Res Rev 2010, 26(6):448-454.
22. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent [J]. J Biol Chem 1951, 193(1):264-275.
23. Bergmeyer HU GPa Assay Methods of Enzymatic Analysis [M] 1974, 293-295. Academic Press, New York. 4th ed.
24. Youngren JF, Goldfine ID, Pratley RE Insulin receptor autophosphorylation in cultured myoblasts correlates to glucose disposal in Pima Indians [J]. Am J Physiol 1999, 276(39):E990-E994.
25. Ye JM, Iglesias MA, Watson DG, et al. PPARalpha/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly [J]. Am J Physiol Endocrinol Metab 2003, 284:E531-E540.
26. Molero JC, Turner N, Thien CB, et al. Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action [J]. Diabetes 2006, 55:3411-3417.
27. Treadway JL, Mendys P, Hoover DJ Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus [J]. Expert Opin Investig Drugs 2001, 10(3):439-454.
28. Rath VL, Ammirati M, Danley DE, et al. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site [J]. Chem Biol 2007, 7(9):677-682.
29. Tiraidis C, Alexacou K, Zographos S, et al. FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase [J]. Protein Sci 2007, 16(8):1773-1782.
30. 123I-labeled insulin and scintigraphic scanning in severe insulin resistance [J]. Diabetes Care 1992, 15(5):651-656.
31. Goodyear LJ, Giorgino F, Sherman LA, et al. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips for obese subjects [J]. J Clin Inv 1995, 95:2195-2204.
32. Jung SH, Ha YJ, Shim EK, et al. Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator [J]. Biochem J 2007, 403:243-250.